Price David 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Aug 3, 2018
Insider Transaction Report
Form 4
Price David
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-08-01+385,000→ 385,000 totalExercise: $2.22Exp: 2028-08-01→ Common Stock (385,000 underlying)
Footnotes (1)
- [F1]The option to purchase will vest and become exercisable in three equal annual installments beginning August 1, 2019.